Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Kalila Medical, a privately held medical device company focused on the development of next-generation steerable catheter technologies, today announced it has received CE mark approval for its Vado Steerable Introducer Sheath for vascular and intracardiac access including Atrial Fibrillation procedures.

8 Jan 2014

Cancer Treatment Centers of America recognized with Clinical Nutrition Team of Distinction Award

Cancer Treatment Centers of America has been recognized by the American Society for Parenteral and Enteral Nutrition with the organization's "Clinical Nutrition Team of Distinction Award". Members of the CTCA professional staff will be honored by A.S.P.E.N at its Clinical Nutrition Week Conference in Savannah, GA this January 2014. This award is presented to multi-discipline clinical teams that exemplify excellence in interdisciplinary clinical nutrition practice in compliance with A.S.P.E.N. standards, guidelines and values.

8 Jan 2014

Second module of PMA application submitted to FDA for Sapheon's VenaSeal Sapheon Closure System

Sapheon Inc. announced today that it has submitted the second module of the pre-market approval application for the VenaSeal Sapheon Closure System to the U.S. Food and Drug Administration.

7 Jan 2014

Cardio3 BioSciences to participate in forthcoming Annual JP Morgan Healthcare Conference

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces its participation in the forthcoming Annual JP Morgan Healthcare Conference in San Francisco, on January 13 to 16, 2014.

30 Dec 2013

Madison Dearborn Partners signs definitive agreement to acquire Ikaria

Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.

25 Dec 2013

Hazards of dietary supplements, new birth control device explored

Dietary supplements account for nearly 20 percent of drug-related liver injuries reported by hospitals, according to The New York Times, while a surge in adverse event reports about Essure, a device hailed as next generation birth control, is explored by the Chicago Tribune. NPR looks at the increase in newborn screening tests.

23 Dec 2013

First Edition: December 23, 2013

The early morning highlights from the major news organizations examine today's deadline for enrolling for health insurance that would begin Jan. 1, as well as a variety of other health law stories and several articles on mental health issues:

23 Dec 2013

CSA Medical announces closing of $16 million Series C financing

CSA Medical, Inc., the leading provider of advanced spray cryotherapy technology that flash freezes unwanted tissue inside the body, today announced that it has closed a $16 million Series C financing led by Ascension Ventures.

20 Dec 2013

ESC presents results of pilot registry on management and treatment of AF in Europe

Results for a pilot registry on the management and treatment of atrial fibrillation in Europe were presented yesterday by the European Society of Cardiology. AF is the commonest cardiac rhythm disorder and each of us have a one-in-four lifetime risk of developing it. Statistics show that oral anticoagulant use has increased, but new oral anticoagulant use is still low. Authors also concluded that compliance with treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal.

20 Dec 2013

Mayo Clinic researchers develop specialized catheter for transplanting stem cells into beating heart

Mayo Clinic researchers and colleagues in Belgium have developed a specialized catheter for transplanting stem cells into the beating heart. The novel device includes a curved needle and graded openings along the needle shaft, allowing for increased distribution of cells.

17 Dec 2013

New technologies unveiled to provide expert care and streamline the process of treating breast cancer

Breast cancer patients are moms, wives, and caretakers. They are teachers, nurses, physicians and heads of industry. Today, more than ever before, women are delicately balancing the various roles of their lives. A breast cancer diagnosis and the treatment that follows is yet another challenge that unfortunately many women need to accommodate in their already busy schedules. That's why Jersey Shore University Medical Center, Ocean Medical Center and Riverview Medical Center offer technologies that provide expert care and streamline the process of treating breast cancer.

14 Dec 2013

PPDC receives $1.5 million grant to advance pediatric medical devices

For medical devices, as with many medicines, the market for children is a small fraction of the adult market, and there are far fewer child-sized devices. But, of course, the need exists, even if proper devices may not.

12 Dec 2013

Findings may help clinicians determine which hospitalized children at greatest risk of VTE

Life-threatening blood clots occur so rarely in children that the condition, known as venous thromboembolism (VTE), is often not on pediatricians' mental radar screens - an absence that can lead to woefully delayed recognition and treatment.

12 Dec 2013

Inflating balloon inside artery after stent placement increases patients' risk of serious complications

Johns Hopkins surgeons say skipping one commonly taken step during a routine procedure to insert a wire mesh stent into a partially blocked carotid artery appears to prevent patients from developing dangerously low blood pressure, an extremely slow heart rate or even a stroke or heart attack.

12 Dec 2013

Avinger closes significant funding round to initiate clinical trial on peripheral atherectomy catheter

Avinger, Inc. producer of therapeutic devices incorporating intravascular imaging and pioneer of the lumivascular approach to treating vascular disease, announced today the closing of a significant funding round.

12 Dec 2013

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

The U.S. Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably by a majority, Yes: 13, No: 1, that the benefits of the WATCHMAN Left Atrial Appendage Closure device outweigh the risks.

11 Dec 2013

Aortic valve implantation does not impair mental capacity of patients

Aortic valve stenosis is the most frequent heart valve defect of older people in Europe - the cause is usually increasing calcification of this important valve. In patients at high and excessive risk, conventional cardiac surgery is often no therapeutic option.

6 Dec 2013

Nurse-led initiatives in Indiana improve patient outcomes

Nurse-led initiatives in Indiana measurably improved patient outcomes while demonstrating anticipated financial savings of more than $5.2 million to their organizations, according to initial results from a hospital-based nurse leadership and innovation training program launched last year by the American Association of Critical-Care Nurses.

6 Dec 2013

USPTO awards patent to Sanovas' Abrading Balloon Catheter for Extravasated Drug Delivery

Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery.

4 Dec 2013

U.S. physicians use CSI's Diamondback 360 Coronary OAS for coronary artery disease treatment

Cardiovascular Systems, Inc., today announced that its new Diamondback 360 Coronary Orbital Atherectomy System is being used by physicians across the country to treat coronary artery disease. This follows the company's recent PMA approval from the U.S. Food and Drug Administration to market the device as a treatment for severely calcified coronary arteries.

3 Dec 2013

Catheter News and Research

Further Reading

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Cancer Treatment Centers of America recognized with Clinical Nutrition Team of Distinction Award

Second module of PMA application submitted to FDA for Sapheon's VenaSeal Sapheon Closure System

Cardio3 BioSciences to participate in forthcoming Annual JP Morgan Healthcare Conference

Madison Dearborn Partners signs definitive agreement to acquire Ikaria

Hazards of dietary supplements, new birth control device explored

First Edition: December 23, 2013

CSA Medical announces closing of $16 million Series C financing

ESC presents results of pilot registry on management and treatment of AF in Europe

Mayo Clinic researchers develop specialized catheter for transplanting stem cells into beating heart

New technologies unveiled to provide expert care and streamline the process of treating breast cancer

PPDC receives $1.5 million grant to advance pediatric medical devices

Findings may help clinicians determine which hospitalized children at greatest risk of VTE

Inflating balloon inside artery after stent placement increases patients' risk of serious complications

Avinger closes significant funding round to initiate clinical trial on peripheral atherectomy catheter

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

Aortic valve implantation does not impair mental capacity of patients

Nurse-led initiatives in Indiana improve patient outcomes

USPTO awards patent to Sanovas' Abrading Balloon Catheter for Extravasated Drug Delivery

U.S. physicians use CSI's Diamondback 360 Coronary OAS for coronary artery disease treatment

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News